PTC Therapeutics, Inc.

PTC Therapeutics Board of Directors Authorizes $500 Million Share Repurchase Program

PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced that its Board of Directors has authorized a share repurchase program under which PTC may…